Latest News about JNJ
Recent news which mentions JNJ
3 Dow Stocks to Sell in September Before They Crash and Burn
September 04, 2023
From InvestorPlace
4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032
September 03, 2023
From Motley Fool
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
September 02, 2023
From Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
From Benzinga
7 Cash Cow Stocks for Recession-Resilient Dividends
September 01, 2023
From InvestorPlace
As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs
September 01, 2023
From MarketWatch
3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth
August 31, 2023
From InvestorPlace
When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong
August 31, 2023
From InvestorPlace
Tickers
JNJ
From Motley Fool
2 Dividend Kings That Face Massive Legal Risks
August 31, 2023
From Motley Fool
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
August 31, 2023
From Motley Fool
Set and Forget: 3 Dividend Stocks Perfect for Your IRA
August 30, 2023
From InvestorPlace
Pharma Giant Johnson & Johnson, Lupin Offer Significant Price Cuts On Tuberculosis Drug
August 30, 2023
Tickers
JNJ
From Benzinga
Johnson & Johnson Reveals Updated 2023 Projections After Finalizing Biggest Shake Up In 135 Years
August 30, 2023
From Benzinga
1 Top Dividend Stock to Buy Hand Over Fist Right Now
August 30, 2023
From Motley Fool
From Motley Fool
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
August 29, 2023
From Benzinga
From MarketWatch
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
From Benzinga
From Benzinga
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
From Benzinga
The 7 Most Promising Blue-Chip Stocks to Own Now
August 28, 2023
From InvestorPlace
7 Reliable Retirement Stocks to Secure a Golden Future
August 28, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
From Benzinga
Viridian Chart Of The Week: How Capital Intensive Is Cannabis?
August 28, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.